BCI Marketplace
Depression Neuromodulation trials

Neuromodulation in Patients With Neuropathic Pain and Depression.

RecruitingNCT06129890Phase: NAStarted 2024-04-26

Summary

High-frequency repetitive transcranial magnetic stimulation of the primary motor cortex has shown its effect on refractory neuropathic pain, and rTMS of the dorsolateral prefrontal cortex is commonly used for treatment-resistant depression. The treatment for patients suffering from neuropathic pain and depression, concomitantly, still needs to be studied, as there are some specificities in both symptoms and brain functional MRI.

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
85 Years

Inclusion Criteria: * Central or peripheral neuropathic pain * Chronic pain (present for more than 6 months) with intensity greater than or equal to 4/10 on the numerical scale * Pain present on a daily or near-daily basis (at least 4 days a week) * Patient not completely relieved by recommended dr

Locations

CHU de Saint-Etienne
Saint-Etienne, France

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →